It also mentioned the debate around vaccination of children under the age of 18 years COVID-19 vaccine booster shots: As many countries around the world are introducing booster shots for COVID-19 vaccine, the Union Government of India has yet to take a stand on the issue. Now, the Delhi High Court has asked the Centre … Read more
These facilities have been facilitating the research in biotechnology for a long time. COVID-19 vaccine in India: As fears of a third wave of coronavirus pandemic are increasing, India has now ramped up its ecosystem for the development and manufacturing of vaccines! Union Minister Hardeep Singh Puri in a post on microblogging site Twitter said … Read more
Covaxin has not been granted permission to be used without restriction, even as Bharat Biotech had sought complete authorisation. Covaxin efficacy: Data from the phase 3 trials of Bharat Biotech’s Covaxin – India’s only indigenous coronavirus vaccine so far – has been shared by the manufacturer, and it shows that symptomatic COVID-19 cases can be … Read more
Hyderabad-based manufacturer Biological E has already received an advanced payment of Rs 1,500 crore from the Centre Coronavirus vaccines in India: When the country faced a shortage of vaccine supply last month, the government had said that it would procure more than 200 crore vaccine doses in the period between April and December this year. … Read more
As of 6 May, Centre says that over 8.9 million (89 lakh) doses are still available with the states/UTs. If the Indian government has paid the two vaccine companies (Serum Institute and Bharat Biotech) for additional vaccine doses, then why is the overall stock of vaccines reduced and also the rate of vaccinations declining? The … Read more
The study which was primarily conducted keeping the UK Covid-19 scenario in mind also did not deal with the question of new variants and their impact on the spread of the disease. Even as countries strive hard to vaccinate their people with the Coronavirus vaccine, a study conducted by the Lancet Infectious Disease Journal has … Read more
Patients suffering from only hypertension or only diabetes would not be eligible, however. Coronavirus vaccination in India: With the next phase of COVID-19 vaccination having begun for people aged above 60 years, or those above 45 years having comorbidities, the government has introduced necessary changes to the system that was in place during the immunisation … Read more
Johnson & Johnson’s vaccine’s efficacy rate came out to be 72% in the clinical trial site in the US. Johnson & Johnson’s COVID-19 vaccine: Johnson & Johnson’s single-shot vaccination against the novel coronavirus SARS-CoV-2 has been approved by the US for emergency use. This means that in the coming week, the rollout of millions of … Read more
The meeting of the Subject Expert Committee of Central Drug Standards Control Organisation is scheduled to be held today to discuss Dr Reddy’s application seeking emergency use approval for Sputnik V vaccine. Covid-19 vaccine India update: The Subject Expert Committee (SEC) of the Central Drug Standards Control Organisation is likely to meet today to take … Read more
As part of the study, the scientists collated the randomised controlled trials data from South Africa, Brazil, and the United Kingdom. Covid-19 vaccine update: In a positive development that could boost the efforts towards Coronavirus vaccination, a Lancet study has found that a three-month interval between the two doses of Oxford University-AstraZeneca vaccine would be … Read more